Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary

  Malignant Melanoma

  Free Subscription


2 Am J Dermatopathol
1 Am J Pathol
1 Ann Surg
2 Ann Surg Oncol
1 Biochem Biophys Res Commun
1 Br J Cancer
3 Br J Dermatol
2 Cancer
1 Cancer Lett
1 Cancer Res
1 Curr Opin Oncol
2 Eur J Dermatol
1 Int J Cancer
3 J Am Acad Dermatol
1 J Clin Invest
2 J Clin Oncol
1 J Immunol
2 J Invest Dermatol
1 Melanoma Res
1 Nat Rev Cancer
1 PLoS Genet
2 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Dermatopathol

  1. MARSCH AF, McKee RM, Hinds BR
    Morphologic Forms and Classification of Dermal Mitotic Figure Density in Primary Cutaneous Melanoma: A Retrospective Study.
    Am J Dermatopathol. 2020;42:35-40.
    PubMed     Text format     Abstract available

    Response to "Melanocytic Nevus Does Not Metastasize".
    Am J Dermatopathol. 2019 Feb 28. doi: 10.1097/DAD.0000000000001381.
    PubMed     Text format    

    Am J Pathol

  3. HAYASHI Y, Jia W, Kidoya H, Muramatsu F, et al
    Galectin-3 Inhibits Cancer Metastasis by Negatively Regulating Integrin beta3 Expression.
    Am J Pathol. 2019;189:900-910.
    PubMed     Text format     Abstract available

    Ann Surg

  4. STAHLIE EHA, Blankenstein SA, van Houdt WJ, Wouters MWJM, et al
    Comment on "Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does Not Provide Reliable Nodal Staging: Results from a Large Multicenter Trial".
    Ann Surg. 2019 Dec 16. doi: 10.1097/SLA.0000000000003696.
    PubMed     Text format    

    Ann Surg Oncol

  5. BELLO DM, Panageas KS, Hollmann T, Shoushtari AN, et al
    Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
    Ann Surg Oncol. 2019 Dec 17. pii: 10.1245/s10434-019-08099.
    PubMed     Text format     Abstract available

  6. UPPAL A, Stern S, Thompson JF, Foshag L, et al
    Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
    Ann Surg Oncol. 2019 Dec 20. pii: 10.1245/s10434-019-08086.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  7. KE J, Wu G, Zhang J, Li H, et al
    Melanoma migration is promoted by prion protein via Akt-hsp27 signaling axis.
    Biochem Biophys Res Commun. 2019 Dec 20. pii: S0006-291X(19)32362.
    PubMed     Text format     Abstract available

    Br J Cancer

  8. ICE RJ, Chen M, Sidorov M, Le Ho T, et al
    Drug responses are conserved across patient-derived xenograft models of melanoma leading to identification of novel drug combination therapies.
    Br J Cancer. 2019 Dec 20. pii: 10.1038/s41416-019-0696.
    PubMed     Text format     Abstract available

    Br J Dermatol

  9. THOMPSON JF, Friedman EB
    The intriguing association between smoking and reduced melanoma risk.
    Br J Dermatol. 2019 Dec 23. doi: 10.1111/bjd.18728.
    PubMed     Text format    

  10. DOCAMPO-SIMON A, Sanchez-Pujol MJ, Belinchon-Romero I, Niveiro M, et al
    Image Gallery: Haematogenous metastasis of melanoma mimicking lymphangioma.
    Br J Dermatol. 2019 Dec 17. doi: 10.1111/bjd.18723.
    PubMed     Text format    

  11. UZUNCAKMAK TK, Akay BN, Ozkanli S
    Different dermoscopic features of clonal seborrhoeic keratoses.
    Br J Dermatol. 2019;180:197-198.
    PubMed     Text format    


  12. KOFF JL, Waller EK
    Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?
    Cancer. 2019;125:838-842.
    PubMed     Text format     Abstract available

    Considering adjuvant therapy for stage II melanoma.
    Cancer. 2019 Dec 23. doi: 10.1002/cncr.32585.
    PubMed     Text format     Abstract available

    Cancer Lett

  14. LIANG Z, Li Y, Tian Y, Zhang H, et al
    High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells.
    Cancer Lett. 2019;447:164-173.
    PubMed     Text format     Abstract available

    Cancer Res

  15. FAILMEZGER H, Muralidhar S, Rullan A, de Andrea CE, et al
    Topological Tumor Graphs: a graph-based spatial model to infer stromal recruitment for immunosuppression in melanoma histology.
    Cancer Res. 2019 Dec 24. pii: 0008-5472.CAN-19-2268.
    PubMed     Text format     Abstract available

    Curr Opin Oncol

  16. HERRSCHER H, Robert C
    Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting.
    Curr Opin Oncol. 2019 Dec 23. doi: 10.1097/CCO.0000000000000610.
    PubMed     Text format     Abstract available

    Eur J Dermatol

  17. TAKIMOTO R, Honda T, Kataoka TR, Ueshima C, et al
    DIHS/DRESS-like eruption possibly induced by amoxicillin during treatment with nivolumab.
    Eur J Dermatol. 2019;29:228-229.
    PubMed     Text format    

  18. ARACTINGI S, Pellacani G
    Computational neural network in melanocytic lesions diagnosis: artificial intelligence to improve diagnosis in dermatology?
    Eur J Dermatol. 2019;29.
    PubMed     Text format     Abstract available

    Int J Cancer

  19. DRAGHI A, Borch TH, Radic HD, Chamberlain CA, et al
    Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs.
    Int J Cancer. 2019;145:1408-1413.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  20. NELSON KC, Gershenwald JE, Savory SA, Wilson JM, et al
    Telementoring and smartphone-based answering systems to optimize dermatology resident dermoscopy education.
    J Am Acad Dermatol. 2019;81:e27-e28.
    PubMed     Text format    

  21. SAVOIA F, Ravaioli GM, Tabanelli M, Dika E, et al
    Scraping test for the diagnosis of acral subcorneal hemorrhage.
    J Am Acad Dermatol. 2019;81:e29-e30.
    PubMed     Text format    

  22. WYSONG A, Higgins S, Blalock TW, Ricci D, et al
    Defining skin cancer local recurrence.
    J Am Acad Dermatol. 2019;81:581-599.
    PubMed     Text format     Abstract available

    J Clin Invest

  23. WALSH SR, Bastin D, Chen L, Nguyen A, et al
    Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity.
    J Clin Invest. 2019;129:518-530.
    PubMed     Text format     Abstract available

    J Clin Oncol

  24. BETOF WARNER A, Postow MA
    Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over Interferon.
    J Clin Oncol. 2019 Dec 27:JCO1902988. doi: 10.1200/JCO.19.02988.
    PubMed     Text format    

  25. TARHINI AA, Lee SJ, Hodi FS, Rao UNM, et al
    Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609.
    J Clin Oncol. 2019 Dec 27:JCO1901381. doi: 10.1200/JCO.19.01381.
    PubMed     Text format     Abstract available

    J Immunol

  26. DANAHY DB, Jensen IJ, Griffith TS, Badovinac VP, et al
    Cutting Edge: Polymicrobial Sepsis Has the Capacity to Reinvigorate Tumor-Infiltrating CD8 T Cells and Prolong Host Survival.
    J Immunol. 2019 Apr 10. pii: jimmunol.1900076. doi: 10.4049/jimmunol.1900076.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  27. BARCELO C, Siso P, Maiques O, Garcia-Mulero S, et al
    T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF(V600E) melanoma: TTCCs are therapy target in BRAF(V600E) melanoma.
    J Invest Dermatol. 2019 Dec 23. pii: S0022-202X(19)33497.
    PubMed     Text format     Abstract available

  28. SHELLMAN MH, Shellman YG
    Human against Machine? Machine Learning Identifies MicroRNA Ratios as Biomarkers for Melanoma.
    J Invest Dermatol. 2020;140:18-20.
    PubMed     Text format     Abstract available

    Melanoma Res

  29. CERCHIO R JR, Marinaro C, Foo TK, Xia B, et al
    Nonhomologous end-joining repair is likely involved in the repair of double-stranded DNA breaks induced by riluzole in melanoma cells.
    Melanoma Res. 2019 Dec 17. doi: 10.1097/CMR.0000000000000652.
    PubMed     Text format     Abstract available

    Nat Rev Cancer

  30. HARJES U
    Helping tumour antigens to the surface.
    Nat Rev Cancer. 2019;19:608.
    PubMed     Text format    

    PLoS Genet

  31. COE EA, Tan JY, Shapiro M, Louphrasitthiphol P, et al
    The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.
    PLoS Genet. 2019;15:e1008501.
    PubMed     Text format     Abstract available

    PLoS One

  32. PERLSTEIN D, Shlagman O, Kogan Y, Halevi-Tobias K, et al
    Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug.
    PLoS One. 2019;14:e0226869.
    PubMed     Text format     Abstract available

  33. KATO Y, Tabata K, Kimura T, Yachie-Kinoshita A, et al
    Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.
    PLoS One. 2019;14:e0212513.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  34. LEE CJ, An HJ, Kim SM, Yoo SM, et al
    FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1909879116.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.